Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Horn, M.
Right arrow Articles by Schlote, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horn, M.
Right arrow Articles by Schlote, W.
Right arrowPubmed/NCBI databases
*Substance via MeSH

(Stroke. 1995;26:290-297.)
© 1995 American Heart Association, Inc.


Articles

Neuron-Specific Enolase in Gerbil Brain and Serum After Transient Cerebral Ischemia

Markus Horn, MD; Florian Seger, MD Wolfgang Schlote, MD

From the Institute of Neurology (Edinger-Institut), University of Frankfurt/Main (M.H., W.S.), and the Department of Neurosurgery, University of Würzburg (F.S.) (Germany).

Correspondence to M. Horn, MD, Department of Neurology, University of Heidelberg, Im Neuenheimer Feld 400, D-69120 Heidelberg, FRG.

Background and Purpose The sensitivity and validity of serum neuron-specific enolase as a marker of brain injury were tested after global cerebral ischemia.

Methods Sixty-nine Mongolian gerbils were perfusion fixed after variable reperfusion after 5-minute (group 1) or 15-minute (group 2) bilateral carotid occlusion. Neuron-specific enolase was analyzed by an enzyme immunoassay in serum of control, sham-operated, and ischemic animals before euthanasia and in nonischemic gerbil brains. Brains were processed for histology, immunohistochemistry, and morphometric evaluation of ischemic neuronal damage.

Results After cerebral ischemia, loss of neuronal immunoreactivity was closely associated with increased neuron-specific enolase serum levels, which were significantly elevated by 24 hours (group 1) or by 4 hours (group 2) of reperfusion (P<.001). Response of serum levels depended on the duration of preceding ischemia, and maximum concentrations were approximately 3-fold (group 1) or 20-fold (group 2) those of nonischemic control. Morphological damage became apparent 48 hours (group 1) or 12 hours (group 2) after ischemia, as indicated by histological and morphometric data.

Conclusions Significantly elevated neuron-specific enolase serum levels could be demonstrated as a consequence of ischemia-induced cytoplasmic loss of neuron-specific enolase in central nervous system neurons, corresponded quantitatively to the severity of cerebral ischemia, and were detectable before irreversible neuronal injury. Therefore, analysis of serum neuron-specific enolase is suggested to be both a valuable diagnostic tool in clinical management of the initial stages of global cerebral ischemia and a prognostic parameter during the postischemic course.


Key Words: cerebral ischemia • neuronal death • neuron-specific enolase • gerbils




This article has been cited by other articles:


Home page
Mol. Cell. ProteomicsHome page
K. Yamane, A. Minamoto, H. Yamashita, H. Takamura, Y. Miyamoto-Myoken, K. Yoshizato, T. Nabetani, A. Tsugita, and H. K. Mishima
Proteome Analysis of Human Vitreous Proteins
Mol. Cell. Proteomics, November 1, 2003; 2(11): 1177 - 1187.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Goswami, N. Kochupillai, P. A. Crock, A. Jaleel, and N. Gupta
Pituitary Autoimmunity in Patients with Sheehan's Syndrome
J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4137 - 4141.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
W. Gartner, W. Lang, F. Leutmetzer, H. Domanovits, W. Waldhausl, and L. Wagner
Cerebral Expression and Serum Detectability of Secretagogin, a Recently Cloned EF-hand Ca2+ -binding Protein
Cereb Cortex, December 1, 2001; 11(12): 1161 - 1169.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
W. Schoerkhuber, H. Kittler, F. Sterz, W. Behringer, M. Holzer, M. Frossard, S. Spitzauer, and A. N. Laggner
Time Course of Serum Neuron-Specific Enolase : A Predictor of Neurological Outcome in Patients Resuscitated From Cardiac Arrest
Stroke, August 1, 1999; 30(8): 1598 - 1603.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. Nollert, M. Nagashima, J. Bucerius, T. Shin'oka, H. G. W. Lidov, A. d. Plessis, and R. A. Jonas
OXYGENATION STRATEGY AND NEUROLOGIC DAMAGE AFTER DEEP HYPOTHERMIC CIRCULATORY ARREST. II. HYPOXIC VERSUS FREE RADICAL INJURY
J. Thorac. Cardiovasc. Surg., June 1, 1999; 117(6): 1172 - 1179.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. T. Wunderlich, A. D. Ebert, T. Kratz, M. Goertler, S. Jost, and M. Herrmann
Early Neurobehavioral Outcome After Stroke Is Related to Release of Neurobiochemical Markers of Brain Damage
Stroke, June 1, 1999; 30(6): 1190 - 1195.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. J. Becker, R. M. McCarron, C. Ruetzler, O. Laban, E. Sternberg, K. C. Flanders, and J. M. Hallenbeck
Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia
PNAS, September 30, 1997; 94(20): 10873 - 10878.
[Abstract] [Full Text] [PDF]